Innovative Research by Dr. Anand Ranganathan and Prof. Shailja Singh Reveals Promising Treatment for Kala-Azar
Innovative Research by Dr. Anand Ranganathan and Prof. Shailja Singh Reveals Promising Treatment for Kala-Azar In a landmark discovery that could revolutionize the treatment of visceral leishmaniasis, commonly known as Kala-azar, Dr. Anand Rangnathan and Prof. Shailja Singh have identified a new peptide inhibitor, PS1, that specifically targets a vital enzyme in the Leishmania donovani … Read more